Quantification of Temozolomide in Nonhuman Primate Fluids by Isocratic Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry to Study Brain Tissue Penetration Following Intranasal or Intravenous Delivery
Open Access
- 4 February 2016
- journal article
- research article
- Published by MDPI AG in Separations
- Vol. 3 (1) , 4
Abstract
A sensitive and selective ultra-high performance liquid chromatography-tandem mass spectrometric method was developed for the quantification of temozolomide (TMZ) in nonhuman primate (NHP) plasma, cerebrospinal fluid (CSF), and brain extracellular fluid (ECF) following microdialysis. Ethyl acetate was used to extract the plasma and CSF samples, using theophylline as the internal standard (IS). ECF samples were diluted with acetonitrile prior to analysis. TMZ was separated on a Waters UPLC® BEH C18 column with an isocratic mobile phase of ammonium acetate (10 mM)-0.1% formic acid/acetonitrile (30:70, v/v) in a positive-ion multiple reaction monitoring mode (m/z 195.5→137.6 for TMZ; m/z 181.5→124.2 for IS). The retention time of TMZ and theophylline was 0.45 min with a total run time of 2.5 min. The method was validated over the range from 5–2000 ng/mL in NHP plasma, CSF, and ECF with respect to linearity, accuracy, precision, selectivity, and stability. This method was successfully applied toward the measurement of pharmacokinetic samples following various routes of drug administration.Keywords
This publication has 18 references indexed in Scilit:
- Double-salting out assisted liquid–liquid extraction (SALLE) HPLC method for estimation of temozolomide from biological samplesJournal of Chromatography B, 2014
- Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma modelCancer Chemotherapy and Pharmacology, 2013
- Development of a new UPLC‐MSMS method for the determination of temozolomide in mice: application to plasma pharmacokinetics and brain distribution studyBiomedical Chromatography, 2013
- The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomasCancer Chemotherapy and Pharmacology, 2012
- Disposition and pharmacokinetics of temozolomide in ratXenobiotica, 2004
- Population pharmacokinetics of temozolomide and metabolites in infants and children with primary central nervous system tumorsCancer Chemotherapy and Pharmacology, 2003
- High-performance liquid chromatographic analysis and stability of anti-tumor agent temozolomide in human plasmaJournal of Pharmaceutical and Biomedical Analysis, 2001
- An LC/MS/MS method for the quantitation of MTIC (5-(3-N-methyltriazen-1-yl)-imidazole-4-carboxamide), a bioconversion product of temozolomide, in rat and dog plasmaJournal of Pharmaceutical and Biomedical Analysis, 1999
- Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trialsCancer Treatment Reviews, 1997
- A RHESUS-MONKEY MODEL FOR CONTINUOUS INFUSION OF DRUGS INTO CEREBROSPINAL-FLUID1990